Oncogenes – The Broken Gas Pedals of Cancer

Estimated reading time: 6 minutes

• What Are Oncogenes? The Definition
• From Good to Evil: How Proto-Oncogenes Become Oncogenes
• 1. Point Mutation: A Small Change with Catastrophic Consequences
• 2. Gene Amplification: Too Much of a Good Thing
• 3. Chromosomal Translocation: A Genetic “Swap” Gone Wrong
• The Consequences of Oncogene Activation: Fueling the Hallmarks
• Conclusion: From Understanding to Targeting

In our journey to understand cancer, we’ve mapped the landscape (Hallmarks of Cancer) and traced the paths of discovery (History of Oncology). Now, we descend to the molecular level to meet the key players that drive the disease. The first of these are oncogenes—the mutated genes that act as stuck “gas pedals,” relentlessly pushing cells to divide.

This lesson is a deep dive into what oncogenes are, how their normal counterparts function, and the precise mechanisms that transform them into engines of cancer. By understanding these fundamental drivers, particularly well-known examples like RAS and MYC, we can begin to see the logic behind targeted therapies and the future of precision medicine.

What Are Oncogenes? The Definition

An oncogene is a mutated form of a normal gene that has the potential to cause cancer. When functioning normally, these genes are called proto-oncogenes. They are essential for normal cell growth, division, differentiation, and survival.

The critical difference lies in their activity:

• Proto-oncogene: Normal, healthy gene that controls cell division. It’s like a well-functioning gas pedal that accelerates the car only when pressed.

• Oncogene: A mutated, hyper-active version of the proto-oncogene. It’s a gas pedal that is stuck to the floor, signaling the cell to divide constantly, regardless of external signals.

Because a single mutated copy of a proto-oncogene is enough to drive abnormal growth, oncogenes are considered dominant at the cellular level.

From Good to Evil: How Proto-Oncogenes Become Oncogenes

Proto-oncogenes are crucial for life. They code for proteins involved in the complex signaling networks that tell a cell when it’s time to grow. These proteins can be:

• Growth factors themselves

• Growth factor receptors on the cell surface

• Intracellular signaling molecules that relay the growth signal

• Transcription factors in the nucleus that turn genes on

When a mutation occurs in a proto-oncogene, it can become a cancer-causing oncogene through several mechanisms. These mutations lead to either:

1. An increase in the protein’s activity.

2. An increase in the amount of the protein produced.

Let’s explore the three primary ways this happens.

1. Point Mutation: A Small Change with Catastrophic Consequences

A point mutation is a single nucleotide change in the DNA sequence of the gene. This small error can alter the structure of the resulting protein, locking it in a permanently “ON” state.

• Classic Example: The RAS Oncogene

  • Normal Function: The RAS protein is a critical relay switch in the cell. When a growth factor binds to a receptor, RAS is temporarily activated (bound to GTP) to pass the “divide” signal downstream. It then quickly deactivates itself (by converting GTP to GDP).

  • The Mutation: A single point mutation in the RAS gene changes the protein’s structure so it can no longer deactivate. It remains stuck in its GTP-bound, active state.

  • The Consequence: The “divide” signal is constantly transmitted, even in the complete absence of growth factors. Mutated RAS is found in approximately 20-25% of all human cancers, including many pancreatic, colorectal, and lung cancers.

2. Gene Amplification: Too Much of a Good Thing

Gene amplification occurs when a cell makes multiple copies of a single proto-oncogene. This doesn’t change the protein itself, but it dramatically increases the number of copies of the gene, leading to a massive overproduction of the protein.

• Classic Example: The MYC Oncogene

  • Normal Function: The MYC protein is a transcription factor, a “master regulator” that binds to DNA and turns on a wide array of genes involved in cell growth, metabolism, and proliferation.

  • The Mutation: The MYC gene is amplified, leading to an abnormally high level of MYC protein in the cell.

  • The Consequence: This flood of MYC protein overwhelms the system, forcing the constant, high-speed expression of growth-related genes. It’s like a conductor forcing an orchestra to play a symphony at a deafening volume and frantic pace. MYC amplification is common in cancers like breast cancer, neuroblastoma, and certain lymphomas.

3. Chromosomal Translocation: A Genetic “Swap” Gone Wrong

A chromosomal translocation happens when a piece of one chromosome breaks off and attaches to another chromosome. If this breakpoint occurs within or near a proto-oncogene, it can place it under the control of a much more active promoter, causing its overexpression.

• Classic Example: The BCR-ABL Oncogene

  • Normal Function: The ABL proto-oncogene codes for a protein involved in cell signaling.

  • The Mutation: In Chronic Myeloid Leukemia (CML), a translocation between chromosomes 9 and 22 (the “Philadelphia chromosome”) fuses the BCR gene with the ABL gene.

  • The Consequence: The resulting BCR-ABL fusion gene produces a hyper-active ABL signaling protein that is constantly “on,” driving the uncontrolled division of white blood cells. This discovery directly led to the development of the targeted therapy imatinib (Gleevec), a landmark achievement in oncology.

The Consequences of Oncogene Activation: Fueling the Hallmarks

The uncontrolled activity of oncogenes directly drives several of the Hallmarks of Cancer we discussed previously:

• Sustaining Proliferative Signaling: This is the primary function of oncogenes. By mimicking or hyper-activating growth signals, they fulfill this hallmark directly.

• Resisting Cell Death: Some oncogenes, like *BCL-2*, work specifically by blocking the apoptosis pathway, allowing damaged cells to survive.

• Deregulating Cellular Energetics: Oncogenes like MYC can reprogram a cell’s metabolism to fuel its rapid growth, a key emerging hallmark.

Conclusion: From Understanding to Targeting

Oncogenes represent one of the two great pillars of cancer genetics (the other being tumor suppressor genes, which we will cover in the next lesson). They are the broken accelerators, the stuck switches, and the overactive signals that initiate and drive the cancer process.

Understanding that these are not “foreign” genes but mutated versions of our own essential genes was a revolutionary insight. More importantly, identifying specific drivers like RAS and BCR-ABL has opened the door to targeted therapies—drugs designed to specifically inhibit the products of these mutated genes. This represents a shift from the blunt instrument of chemotherapy to a precision strike against the heart of a cancer cell’s machinery.

---

Suggested External Links for Authoritative Information:

• National Cancer Institute: Oncogenes

• Nature Scitable: Proto-oncogenes to Oncogenes